Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
stock market news, ai eye podcast 525 gbt target radio system for use i 4654151989499024

ASMB Quote, Trading Chart, Assembly Biosciences Inc.


home / stock / asmb / asmb quote

$5.05 Last:

-0.59% Change Percent:

$5.1493 Open:

$5.05 Previous Close:

$5.23 High:

$5.02 Low:

1,835,177 Volume:

03/01/2021 04:55:13 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2021-03-015.14935.055.235.021,835,177
2021-02-265.21395.085.545.072,384,627
2021-02-255.685.535.835.412,294,002
2021-02-245.645.645.695.471,464,203
2021-02-235.65.465.635.251,980,538
2021-02-225.815.735.965.71,487,440
2021-02-195.865.836.085.831,764,838
2021-02-186.015.796.025.751,254,142
2021-02-176.186.096.261,096,931
2021-02-166.316.146.346.031,616,261
2021-02-156.366.296.39016.18935,032
2021-02-126.366.296.39016.18927,236
2021-02-116.596.376.626.222,078,993
2021-02-107.00816.597.026.252,991,369
2021-02-096.626.6376.573,311,790
2021-02-086.286.456.496.192,866,596
2021-02-056.196.156.25756.0751,132,166
2021-02-046.076.126.166.011,907,452
2021-02-035.896.016.015.851,456,185
2021-02-025.835.845.885.741,194,122
Stock Information

Assembly Biosciences Inc. Company Name:

ASMB Stock Symbol:

NASDAQ Market:

Assembly Biosciences Inc. Website:

MENU
ASMB ASMB Quote ASMB Short ASMB News ASMB Articles ASMB Message Board
Get ASMB Alerts

News, Short Squeeze, Breakout and More Instantly...

stock market news, ai eye podcast 525 gbt target radio system for use i 4654151989499024
RECENT ASMB NEWS
  • ASMB - Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of Triple Combination Therapy for the Treatment of Chronic Hepatitis B Virus

    Trial will evaluate Assembly’s core inhibitor candidate, vebicorvir, with Arbutus’ RNAi therapeutic candidate, AB-729, and standard-of-care NrtI therapy SOUTH SAN FRANCISCO, Calif., and WARMINSTER, Pa., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasd...

  • ASMB - Assembly Biosciences Reports Fourth Quarter and Year End 2020 Financial Results and Recent Highlights

    SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today reported financial results and recent highlights for the fourth quarte...

  • ASMB - Assembly Biosciences Updates Pipeline Strategy, Focusing on Finite and Curative Therapies for Chronic Hepatitis B Virus Infection

    - Prioritizing next generation, more potent core inhibitors, triple combinations with complementary mechanisms of action, and expanding research programs to advance multiple candidates against novel targets - Extends cash runway into 2023 - Company to host conference call toda...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact
x
stock market news, ai eye podcast 525 gbt target radio system for use i 4654151989499024

Important Investor News Alert (OTCMKTS: GTCH)

 Logo

  • GTCH - AI Eye Podcast 525: GBT Target Radio System for Use in Global Communications for Remote Applications, and C3 AI Awarded Patent for AI Suite

    Point Roberts, WA and Vancouver, BC - February 26, 2021 (Investorideas.com Newswire) Investorideas.com ( www.investorideas.com ), a global investor news source covering Artificial Intelligence (AI) brings you today's edition of The AI Eye - watching stock news, deal tracker and adva...

Sign up or login to continue

Sign up or login to continue.


Forgot password?




WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Member Benefits

Member Coins


Log In

Sign Up

Stay Connected
Follow @marketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News